Skip to content

Avanos MCKA3-17-75-4

by Avanos Medical, Inc.

Avanos MCKA3-17-75-4 is a Class II device made by Avanos Medical, Inc., listed in FDA GUDID since 11 Mar 2021 (UDI-DI 00193493478866), registry data as of 23 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00193493478866 UDI-DI Date11 Mar 2021ListedStatusListed GUDID: in commercial distribution

Official records

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
Avanos
Generic name
Percutaneous radio-frequency ablation probe cannula, single-use
Model / Ref / Catalog
MCKA3-17-75-4
Primary DI / UDI-DI
00193493478866
FDA product code
GXI
GMDN term
Percutaneous radio-frequency ablation probe cannula, single-use
Device class
Class II
Regulation number
882.4725
GUDID distribution status
In Commercial Distribution

Related devices

Category: Neurosurgical procedure kit, non-medicated, single-usePercutaneous radio-frequency ablation probe cannula, single-usePercutaneous radio-frequency ablation probe, denervation, monopolar, single-usePercutaneous radio-frequency ablation probe, denervation, bipolar

Similar devices

Other devices filed under FDA product code GXI (Probe, radiofrequency lesion).

Other devices from Avanos Medical, Inc.

See all devices from Avanos Medical, Inc. →

Properties

  • Supplied sterile
  • Single use
  • Prescription use
  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (9, all answered No)